Sprott关键材料ETF SETM 深 沪
等待开盘 05-19 09:30:00 美东时间
34.61
-0.620
-1.76%
华盛通- 最 高35.7008
- 今 开35.69
- 成交量 36.20万股
- 最 低 34.2001
- 昨 收 35.23
- 总市值 62.89万
- 52周最高 40.55
- 市盈率 静 --
- 换手率 1992.39%
- 52周最低 14.3873
- 委 比 -5.66%
- 总股本 1.82万
- 历史最高 40.55
- 量 比 1.29
- 振 幅 4.26%
- 历史最低 11.0273
- 每 手 1
- 风险率 7.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多'Worst-Ever Energy Shock' Drives Focus Toward Australian Uranium
IEA's Fatih Birol warns of the "worst-ever energy shock." Why the Middle East crisis is shifting the focus from oil to critical minerals.
03-26 19:20
US $12 Billion Critical Minerals Stockpile Puts Rare Earth ETFs Back In Focus
Trump's $12 billion U.S. critical minerals stockpile plan could boost rare earth and mining ETFs while spotlighting supply-chain security and China exposure.
02-03 01:39
Global Critical Minerals Rely On International Trade, Study Shows Critical Vulnerabilities
International trade meets 60% of critical mineral demand but faces risks like geopolitical tensions and supply chain disruptions.
2025-12-23 19:21
BRIEF-Rhythm Pharmaceuticals Announces Preliminary Data From Exploratory Phase 2 Trial That Showed Setmelanotide Demonstrated Positive Efficacy Signal In Prader-Willi Syndrome
Dec 11 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O: RHYTHM PHARMACEUTICALS ANNOUNCES PRELIMINARY DATA FROM EXPLORATORY PHASE 2 TRIAL THAT SHOWED SETMELANOTIDE DEMONSTRATED POSITIVE EFFICACY SIGNAL I...
2025-12-11 20:34
BRIEF-Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE (setmelanotide) for Patients with Acquired Hypothalamic Obesity
Nov 7 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O: RHYTHM PHARMACEUTICALS ANNOUNCES FDA EXTENSION OF REVIEW PERIOD FOR IMCIVREE® (SETMELANOTIDE) FOR PATIENTS WITH ACQUIRED HYPOTHALAMIC OBESITY RHYTH...
2025-11-07 20:41
Sprott Critical Materials ETF Reaches $100 Million in Assets
Sprott's Critical Materials ETF (SETM) has reached $100 million in assets under management, offering the only pure-play exposure to critical materials essential for energy demand growth. The ETF includes uranium, copper, lithium, nickel, cobalt, and rare earths, focusing on upstream mining companies. CEO John Ciampaglia highlights growing supply-demand gaps in electrification materials, driving investment opportunities. SETM is part of a suite of...
2025-10-14 12:00
Sprott Launches Active Metals & Miners ETF
Sprott Inc. has launched the Sprott Active Metals & Miners ETF (METL), an actively managed ETF targeting long-term capital appreciation by investing in metals and mining companies. METL employs a value-oriented, contrarian strategy, focusing on undervalued firms with strong fundamentals or growth potential. The ETF's team, led by Justin Tolman, has extensive industry experience and combines top-down sector analysis with bottom-up stock selection....
2025-09-10 12:00
BRIEF-Rhythm Pharmaceuticals Announces FDA Acceptance Of sNDA For Setmelanotide In Acquired Hypothalamic Obesity
Aug 20 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O: RHYTHM PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF SNDA FOR SETMELANOTIDE IN ACQUIRED HYPOTHALAMIC OBESITY RHYTHM PHARMACEUTICALS INC - FDA GRANTS...
2025-08-21 04:04
BRIEF-Rhythm Pharmaceuticals Says Phase 2 Signal Trial Shows Bivamelagon Reduces BMI In Hypothalamic Obesity
July 12 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O: RHYTHM PHARMACEUTICALS INC - PHASE 2 SIGNAL TRIAL SHOWS BIVAMELAGON REDUCES BMI IN HYPOTHALAMIC OBESITY RHYTHM PHARMACEUTICALS INC - PHASE 3 TRAN...
2025-07-13 06:10
From Mine To Magnet: MP Materials, Maaden Plan Rare Earth Chain In Saudi Arabia
MP Materials Corp. (NYSE: MP) has partnered with Maaden to explore creating a full rare earth supply chain in Saudi Arabia, boosting industrial growth.
2025-05-14 23:05
